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The use of materials, containing the biocompatible and bioresorbable biopolymer poly(1 → 4)-2-amino-2-deoxy-β-D-glucan,
containing some N-acetyl-glucosamine units (chitosan, CHI) and/or its derivatives, to fabricate devices for the regeneration of
bone, cartilage and nerve tissue, was reviewed. The CHI-containing devices, to be used for bone and cartilage regeneration and
healing, were tested mainly for in vitro cell adhesion and proliferation and for insertion into animals; only the use of CHI in dental
surgery has reached the clinical application. Regarding the nerve tissue, only a surgical repair of a 35mm-long nerve defect in
the median nerve of the right arm at elbow level with an artificial nerve graft, comprising an outer microporous conduit of CHI
and internal oriented filaments of poly(glycolic acid), was reported. As a consequence, although many positive results have been
obtained, much work must still be made, especially for the passage from the experimentation of the CHI-based devices, in vitro
and in animals, to their clinical application.
1. Introduction
Chitosan (CHI) is a poly(1 → 4)-2-amino-2-deoxy-β-D-
glucan, containing some N-acetyl-glucosamine units (Fig-
ure 1), obtained by partial deacetylation of chitin, the main
component of the exoskeleton of crustaceans, and it is gen-
erally considered as biocompatible and biodegradable [1, 2];
chitin and CHI are the most abundant polysaccharides
among those containing amino sugars [3]. CHI was used
some years ago, by the authors’ group, as a template for
the polymerization of acrylic acid and sodium 4-sty-renes-
ulfonate [4]; the polyelectrolyte complex obtained with the
first monomer showed a good cytocompatibility, while that
with the second one seemed to influence negatively the cell
proliferation [5]. Very many studies have been done on CHI
and its derivatives as materials for the fabrication of scaﬀolds,
used for tissue engineering and regeneration. The early stud-
ies about the possibility of using CHI and its derivatives in
the food and biomedical sciences sand industries regarded
mainly the immobilization of enzymes on the polysaccharide
[6, 7]. The results obtained in this field up to 1980 were the
argument of a review by A. Muzzarelli [3]. Another inter-
esting argument of these early studies regarded the chelating
ability of CHI towards metal cations [8–10], which was
found later to facilitate the tissue mineralization in tooth im-
plantation [11]; furthermore, it was proposed more re-
cently that the CHI-metal interaction modes might be in-
volved in the controlled bioactivity of CHI [12]. In 2005,
R. A. A. Muzzarelli and C. Muzzarelli thoroughly re-
viewed the researches made on CHI and its deriva-
tives as biomaterials [13]. In 2008, Korean biotechnolo-
gists reviewed the use of CHI and CHI derivatives for
tissue engineering of various organs, between which there
were bone, cartilage, and nerves [14]. This paper will
summarize mainly the current body of growing literature,
where a use of CHI for cartilage, bone, and nerve tissue
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Figure 1: Structure of a chitosan with about 25% of acetylated repeating units.
regeneration was reported, because of their importance in
themobility and sensitivity of human body. The use of CHI, a
completely bioresorbable material [1, 2], permits solving the
main problems arising in the orthopaedic and neurological
surgery: first, the substitution of damaged cartilage and bone
with permanent prostheses of foreign biomaterials could not
assure the same tribological andmechanical properties as the
natural bone and cartilage, whose complete regeneration is
preferable, when possible; second, the unique function of the
nerve tissue can be fully restored only by regenerating it.
2. Characterization of CHI-Based Biomaterials
Regarding the analytical studies on CHI and its derivatives,
some of them were carried out in view of a use of the poly-
saccharide in the biomedical field. Japanese researchers pre-
pared and characterized polyion complexes formed by the
reaction between CHI and the anionic polyelectrolyte gellan
[15]; the complexes were structured in fibres and capsules,
which were said to be able, when filled with either drugs or
growth factors, to release them into the injured part of the
body, during the biodegradation of the component biopoly-
mers [16]. However, in a following study of the same au-
thors, the biodegradation of the polyion complex fibres was
found to occur via soil filamentous fungi, so that they were
proposed as environmentally biodegradable materials [17].
This fact throws many doubts on the possible use of these
fibres as bioresorbable materials within the body. The bio-
chemistry, the histology, and the clinical uses of chitins and
chitosans for the treatment of leg ulcers, the use of skin sub-
stitutes, and the regeneration of nerve, meniscus, and bone
tissues were thoroughly reviewed by A. Muzzarelli et al. in
1999 [18]. Regarding the nerve regeneration, they cited an
early paper of Zielinski and Aebischer, who found that the
fibroblast cells R208N.8 released nerve growth factor, when
sequestered in 60 : 40 acrylonitrile-vinyl chloride copolymer
containing precipitated CHI as an internal matrix [19]. Re-
garding the meniscus, Muzzarelli et al. found that CHI stim-
ulated its repair by providing the necessary tissue elements
and humoral factors. Regarding the bone tissue, they re-
viewed all the work then made, both in vitro and in vivo. A
short review by Babensee et al., regarding the growth factor
delivery also from CHI-albumin microspheres, for muscu-
loskeletal, neural, and hepatic tissue engineering, appeared
in the following year. However, CHI-albumin microspheres
were used only for the growth of hepatocytes [20]; then, they
were not useful for cartilage, bone, and nerve regeneration.
CHI was grafted onto silk fibroin by means of mushroom
tyrosinase through the reaction of the amino groups of CHI
with the tyrosyl residues of the protein, oxidized enzymati-
cally to o-quinone groups; the resulting copolymer was ana-
lyzed, with the aim of enhancing the biocompatibility of silk-
based biomedical devices in the hosting biological environ-
ment [21]. However, products of the same reaction, carried
out under heterogeneous conditions, seemed to be, for their
authors, more interesting as structural polymers than as bio-
medical ones [22]. The interactions with bovine serum al-
bumin of two CHI macromolecules, having acetylation de-
grees of 1% and 12%, were measured by means of the tur-
bidity change with varying pH, in 0.1M NaCl solution. The
results were presented as a model for enzyme immobilization
on CHI, but no test with enzymes was reported [23]. Bio-
degradable blend membranes composed of CHI, and either
poly(d,l-lactide) or poly(l-lactide) was prepared using a so-
lution-casting and solvent-extracting processing technique.
The membranes were examined by means of SEM, FTIR,
TGA, DSC, DMA, and X-ray diﬀraction to test themiscibility
of the polymers, which depended strongly on the polymer
concentration and on the composition ratio of the mixed
solvents, as well as on the drying technique. In the blends pre-
pared under optimized processing conditions, FTIR showed
hydrogen bond interactions between the polymers, which
also caused a lowering of their crystallinity, detected by X-ray,
thermal and dynamical testing, so indicating a goodmiscibil-
ity [24]. Fluorescein was attached, via its epoxy derivative, to
water-soluble CHI, and the temperature/pH-sensitive qual-
ities of fluorescence were investigated; the results obtained
indicated that this modified CHI could be able to provide
a convenient way to prepare low-cost and multifunctional
macromolecular biomaterial for determining pH and tem-
perature changes in biological systems simultaneously [25].
Bioartificial biodegradable materials were prepared, by the
authors’ group, by mixing CHI and poly(vinyl alcohol); then
they weremanufactured as films and finally cross-linked with
pentane-2,5-dial (glutaraldehyde), both in the absence and
in the presence of the edible plasticizer sorbitol, with the aim
of using them as biomaterials and, in particular, as localized
drug carriers. The materials were characterized by means of
FTIR, DSC, TGA, X-ray diﬀraction, SEM, and tensile test
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[26]. The blends showed a good biodegradability [27] and,
as toughened by dehydrothermal treatment, no cytotoxicity
toward murine fibroblasts [28]; their ability for drug re-
lease and permeation, tested for ascorbic acid, paclitaxel,
D(+)glucose, vitamin B12, and bovine serum albumin, was
found to depend on the chemical structures and properties
of the testedmolecules [27, 28]. The results obtained indicate
that these blends could be useful to make both scaﬀolds for
tissue engineering and devices for drug delivery. Canadian
researchers fractionated and characterized CHI by size-ex-
clusion chromatography and 1H NMR, to produce homoge-
neous monodisperse chitosans in the molecular weight range
of 5–100 kDa, which were said to be particularly useful in bi-
omedical applications such as gene delivery; however, no
results in the biomedical field were reported [29]. Japanese
researchers modified an AFM probe by depositing on its tip,
through amicropipette controlled bymicromanipulator, first
an acetone solution of poly(lactic-co-glycolic acid) and then
a CHI solution in ethanol. The modified probe was used to
study the interaction between the polymers and amucin film,
to understand the mucoadhesive mechanisms of CHI, when
used for oral mucosal drug delivery. It was revealed that when
a poly (lactic-co-glycolic acid) probe is retracting from the
mucin film, a repulsive force appeared; however, after the
probe was further overcoated with CHI, the force became
attractive if the amount of CHI was enough, such as at CHI
concentrations of 0.2% w/v [30]. Chinese researchers pre-
pared a stable and translucent novel composite film consist-
ing of CHI and cortical cells, extracted fromwaste wool fibres
and characterized it by SEM, FTIR, DSC, X-ray diﬀraction,
and tensile test. This film has a potential utilization in many
fields, such as food packaging, wound dressing, and also tis-
sue engineering [31]. Canadian researchers used AFM and
AFM-based force spectroscopy, with CHI-modified tips, to
investigate desorption of individual CHI polymer chains
from substrates with varying chemical composition. They
concluded that the experimental results reported in their
paper might be used as a basis to investigate the interaction
of CHI with surfaces, which may later be used as coatings in
biomaterial applications, although no application in this field
has been reported at the present time [32]. A new label-free
amperometric immunosensor was developed for detection of
human chorionic gonadotrophin, based on a multiwall car-
bon nanotubes-CHI complex film, electrodeposited on a
glassy carbon electrode, and a three-dimensional Au nan-
oparticles-TiO2 hybrid. The ease of the nonmanual tech-
nique and the promising features of this composite were
presented by these researchers as a possible versatile platform
for constructing other biosensors [33]. Direct formation of
porous CHI structures, to be used as scaﬀolds for cell culture,
by supercritical carbon dioxide method was presented to an
international conference in India in 2009 [34]. In the same
year, a review appeared, regarding chitins and chitosans for
the repair of wounded skin, nerve, cartilage, and bone [35].
Generally, these analytical studies pointed out the suitability
of CHI and of its derivatives to be used in the biomedical
field, mainly for tissue engineering and regeneration, as well
as for drug and gene delivery.
3. Bone and Cartilage Regeneration
An early work in the field of the chondroskeletal tissue en-
gineering regarded the use of a CHI ascorbate gel for the
treatment of periodontitis, according to current dental sur-
gery; in ten patients, two months after the treatment, CHI
was completely reabsorbed and the periodontiumwell regen-
erated [36]. The positive results of this pioneering clinical
application encouraged the researches on the use of CHI
containing biomaterials for bone and cartilage regeneration.
3.1. Bone. Methyl pyrrolidinone CHI was used to favour the
formation of new bone tissue within the large alveolar cavity,
remaining after the avulsion of a wisdom tooth [37]. The
use of imidazolyl and 2-methyl-imidazolyl CHI for bone le-
sion healing was tested on sheep femoral condyles [38]. A
particularly interesting feature was the use of CHI and its
derivatives for the treatment of osteoporosis, a possible phys-
icochemical component which was recently studied by the
authors’ group [39]. The release, as a consequence of CHI
biodegradation, of the bone morphogenetic protein BMP-7
(OP-1), linked to an N,N-dicarboxymethyl CHI matrix in
the form of a polyelectrolyte complex, was tested on the fem-
oral condyles of four female osteoporotic rats. After 30 days,
a complete new bone formation was observed in the surgical
bone defects [40]. In another research [41], the same osteo-
porotic rats were treated with only hydroxyapatite and two
biological glasses, with rather scarce results, whilst a CHI-
hydroxyapatite composite was successfully inserted in fem-
oral condyles of healthy New Zealand rabbits. N,N-dicar-
boxymethyl CHI was found to chelate calcium and phos-
phate ions, forming a gel, which favoured osteogenesis
while promoting bone mineralization. Bone regeneration
was observed in bone defects surgically made in sheep fem-
oral condyle and trochanter [41, 42], as well as in human
mandible after tooth avulsion and cyst removal [42]. Surgical
lesions in rat condylus were treated with N,N-dicarbox-
ymethyl CHI and the sodium salt of 6-oxychitin. Morpho-
logical data indicate that 6-oxychitin promoted the best
osteoarchitectural reconstruction, even though healing was
slower compared to that with N,N-dicarboxymethyl CHI.
Complete healing was obtained with N,N-dicarboxymethyl
CHI within three weeks [43]. A blend of CHI gel, ionically
cross-linked with ascorbic acid, ZnO, CaO, crystalline car-
bonate-hydroxyapatite, and NaF, was prepared and tested
by chemical, physical, and crystallographic measurements,
with the aim of obtaining an eﬃcient dressing for use
during regeneration of the periodontal barrier [44]. A review
focused on the manufacture of CHI-inorganic composites,
based on calcium carbonate, calcium phosphate, and silica,
pointed out their importance in the field of blood compatible
materials, bone substitutes, and cements for bone repair and
regeneration [45]. Biodegradable polylactide/CHI blends
were used to fabricate scaﬀolds with well-distributed and
interconnected porous structures. The porosity and the pore
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dimension were monitored to obtain scaﬀolds suitable for
applications in cartilage or bone tissue engineering [24, 46].
A more recent work regarded a good influence of the CHI
component on the interactions between those blends and
rat osteoblasts [47]; however, at the present time no clinical
application of them has been reported. The bioactivity of a
novel composite of carbonate-containing low-crystallinity
nanoparticle hydroxyapatite and a CHI–phosphorylated CHI
polyelectrolyte complex was evaluated in vitro and in vivo.
The material was cocultured with rat osteoblasts in vitro and
implanted into rabbit femur marrow cavities. The results
indicated that the composite promoted osteoblast adhesion,
morphology, proliferation, and diﬀerentiation in vitro; the
bone tissue response in vivo to the material showed that the
composite provided a suitable environment for active bone
formation, with marrow cell infiltration and new bone dep-
osition around the powder; then, it was bioactive as well as
biodegradable [48]. Chitin and CHI were used to fill the
defects in fractured segments of radius and ulna of dogs
after stabilizing with dynamic compression plates. The study
revealed that the fracture healing was better in CHI group of
dogs [49]. Taiwan researchers produced a CHI surface-bond-
ed recombinant human bone morphogenetic protein 2 via
amide bond formation between the components. The sur-
face-bonded protein did not denature but expressed sus-
tained biological activity, such as osteoblast cell adhesion,
proliferation, and diﬀerentiation, so making the material
useful for bone tissue regeneration [50]. Korean researchers
prepared porous, biodegradable and biocompatible scaf-
folds, using CHI, CHI with natural hydroxyapatite derived
from Thunnus Obesus bone, and CHI grafted with func-
tionalized multiwalled carbon nanotube, via freeze-drying
method, and characterized them physiochemically as bone
graft substitutes. Cell proliferation in composite scaﬀolds was
twice than in pure CHI when checked in vitro using a human
osteosarcoma cell line [51]. The preparation and character-
ization of CHI-blended polyamide-6 nanofibres by a new
single solvent system via electrospinning process for human
osteoblastic cell culture applications were carried out. The
in vitro cytotoxicity evaluation of these nanofibres indicated
that this scaﬀold material was nontoxic for the osteoblast cell
culture [52]. A Brazilian research group synthesised a porous
chitosan-gelatin scaﬀold cross-linked by glutaraldehyde and
characterized it by both physicochemical and morphological
tests, as well as investigating its eﬀects on growth and oste-
ogenic diﬀerentiation of rat bonemarrowmesenchymal stem
cells. Free-cell scaﬀolds were implanted into tooth sock-
ets of Lewis rats after upper first molars extraction; on the
21st day, alveolar bone and epithelial healing were completely
established [53]. Recently, Muzzarelli reviewed the use, for
bone regeneration, of CHI composites with inorganic mate-
rials, morphogenetic proteins, and stem cells [54]. As a
whole, despite the numerous positive results obtained from
the tests made both in vitro and in animals, at the present
time CHI-containing biomaterials have not yet reached the
clinical application for human bone tissue regeneration, with
the only exception of dental surgery. Also a very recent
Russian patent, regarding a porous sponge of chitosan-
gelatin composite with octacalcium phosphate, suitable for
filling of bone defects, does not contain, in its abstract, any
mention of having obtained the government approval for its
use in clinical orthopaedic practice [55].
3.2. Cartilage. N-Carboxybutyl CHI was used to promote
the tissue repair of the meniscus in rabbits [56]. Recombi-
nant bone morphogenetic protein BMP-7 (OP-1), linked to
a N,N-dicarboxymethyl CHI matrix in the form of a pol-
yelectrolyte complex, was used to induce or facilitate the
repair of articular cartilage lesions, produced in 21 adult male
New Zealand white rabbits [57]. In situ gelling CHI-diso-
dium β-glycerol phosphate-glucosamine solution, contain-
ing chondrocytes, was injected into cartilage defects in rab-
bits. The results showed that the delivered cells could grad-
ually produce a viable and mechanically stable repair tissue
at the defect site [58]. Another group inserted a hydrogel
of CHI-hyaluronan polyelectrolyte complex into the patella
articular cartilage of rabbits, obtaining some promising
results. The implants were capable of developing hyaline-
appearing tissue, maintained at 24 weeks postoperatively; the
presence of chondrocytes was also observed [59]. CHI-glyc-
erol phosphate/blood implants applied in conjunction with
drilling, compared to drilling alone, elicited a more hyaline
and integrated repair tissue associated with a porous sub-
chondral bone repleted with blood vessels, in New Zealand
white rabbits. Concomitant regeneration of a vascularized
bone plate during cartilage repair could provide progenitors,
anabolic factors, and nutrients that aid in the formation of
hyaline cartilage [60]. An analogous treatment, made on
identical rabbits subjected to bilateral arthrotomies, with
each trochlea receiving a cartilage defect bearing four micro-
drill holes into the subchondral bone, favored intramembra-
nous bone formation in the microdrill holes and resulted in
a cartilage repair strategy that modulates acute and interme-
diate events in the subchondral bone in order to improve
final cartilage repair outcome [61]. The proliferation in
vitro of New Zealand white rabbit chondrocytes on porous
poly(dl-lactide)/chitosan scaﬀolds was studied using scan-
ning electron microscopy, histological observations, and
proteoglycan measurements; the results indicated that the
resulting scaﬀolds exhibited increasing ability to promote
the attachment and proliferation of chondrocytes and also
helped the seeded chondrocytes to spread through the
scaﬀolds and distribute homogeneously inside them [62].
Korean researchers obtained thermosensitive gels grafting
N-isopropylacrylamide onto CHI and coupling CHI with
Pluronic, a commercial poly(ethylene oxide-b-propylene ox-
ide) triblock copolymer [63]. The first copolymer induced
the chondrogenic diﬀerentiation in vitro of human mes-
enchymal stem cells [63]; the second one favoured the prolif-
eration in vitro of bovine chondrocytes [64]. Temperature-
responsive CHI hydrogels were prepared by combining
CHI, β-sodium glycerophosphate, and hydroxyethyl cellu-
lose. Tissue-engineered cartilage-regenerating scaﬀolds were
made in vitro by mixing sheep chondrocytes with a CHI
hydrogel. To collect data for in vivo repair, scaﬀolds cultured
for one day were transplanted to the freshly prepared defects
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of the articular cartilage of sheep. The results showed that
the chondrocytes in the regenerated cartilage survived and
retained their ability to secrete matrix when cultured in
vitro. The scaﬀolds induced complete cartilage defects repair
within 24 weeks after being transplanted in vivo [65].
Canadian researchers successfully investigated temporal and
spatial modulation of chondrogenic foci in subchondral
microdrill holes, made in 32 New Zealand white rabbits, by
CHI-glycerol phosphate/blood implants. The chondrogenic
foci bore some similarities to growth cartilage and could give
rise to a repair tissue having similar zonal stratification as
articular cartilage [66]. In the field of cartilage regeneration,
the research on CHI is less advanced than in that of bone,
considering the absence of clinical applications in humans.
4. Nerve Tissue Regeneration
Chinese researchers studied the ability of materials made
with CHI and CHI derivatives to facilitate the in vitro
growth of nerve cells for nerve tissue regeneration. Their re-
sults suggested that, after being precoated with laminin and
fibronectin solution or serum, all materials have better nerve
cell aﬃnity [67]. More recently, the same group found that
films of carboxymethyl chitosan, cross-linked with 1-ethyl-
3(3-dimethylaminopropyl) carbodiimide hydrochloride, en-
hanced the spread of Neuro-2a cells and provided a good
proliferation substratum for Neuro-2a cells, as compared to
chitosan films [68]. In a much later research, that group in-
vestigated the application of the CHI/glycerol-β-phosphate
disodium salt hydrogel in peripheral nerve regeneration, in
24 female adult Sprague Dawley rats. Contrary to former
in vitro reports, they found that the implanted hydrogel
actually impeded nerve regeneration; then, many further
studies are necessary in this matter [69]. Japanese researchers
coated apatite CHI tubes prepared from crab tendons and
then used them as nerve-regenerating guides for the sciatic
nerves of male Sprague Dawley rats, with successful results
[70]. Researcher of the University of Texas reviewed the
strategies for repair and regeneration of damaged nerves,
among which there was the use of nerve guides made by
bioresorbable materials, including CHI [71]. Chinese re-
searchers developed a dual-component artificial nerve graft
comprising an outer microporous conduit of CHI, made
from crab tendons, and internal oriented filaments of
poly(glycolic acid). The novel graft was used for bridging
sciatic nerve across a defect of 3 cm length in six Beagle dogs;
they were compared with other six dogs subjected to au-
tograft, as a positive control, and with five not grafted dogs,
as a negative control. At six months postoperatively, the dogs
grafted with the artificial nerve showed motion ability com-
parable to that of the positive control ones, unlike the not
grafted ones [72]. Italian researchersmade in vitro neuroblast
adhesion test on films of CHI-gelatin blends and on nerve
guides of CHI-poly(ε-caprolactone) blends; the cells adhered
better to the first materials than to the second ones [73]. AUS
research team prepared nerve guides with a blend of CHI and
type I collagen from rat-tail tendon, as well as guides of pure
CHI. Each guide group was used to bridge a 10mm sciatic
nerve gap of 24 female Lewis rats; equal numbers of rats were
subjected to autograft and left unrepaired, respectively,
as positive and negative controls. Both guides gave quite
good results, although less than autograft; the researchers
concluded that further investigation was necessary [74]. A
Chinese group fabricated nerve conduits of a CHI-poly(lactic
acid) blend, using a mold casting/infrared dehydration tech-
nique. The conduits were inserted in 10mm gaps of the sci-
atic nerves of ten 4-month-old Sprague Dawley rats; equal
numbers of rats were treated with autograft and silicone con-
duits, respectively. The nerve regeneration with the blend was
not diﬀerent from that with the autograft, and much better
than with the silicone [75]. A group of the Purdue University,
USA, performed ex vivo and in vivo experiments on spinal
cord injuries made in guinea pigs. Their results demonstrated
that the application of CHI was able to immediately restore
compromised membrane integrity, CHI was a potent neuro-
protective agent, even though it did not show any ability to
scavenge either reactive oxygen species or acrolein, and that
CHI clearly targeted the area of tissue damage, where unin-
jured spinal cord exhibited a very weak aﬃnity for CHI.
Then, the CHI approach for damaged membranes provides
novel therapeutic potential through site-specific delivery fol-
lowing traumatic spinal cord and head injury [76]. Canadian
researchers found that CHI could be promising in trans-
plantation strategies of neural stem and progenitor cells, to
treat an injury to the central nervous system, such as a spinal
cord injury. Four amine-functionalized hydrogels, comprised
CHI, were screened in vitro for the viability, the migration,
and the diﬀerentiation of adult murine neural stem and pro-
genitor cells. Only CHI supported survival of multipotent
stem cells and the diﬀerentiation of the progenitor cells into
neurons, astrocytes, and oligodendrocytes. Then, CHI ap-
peared as a promising material for the therapies involving
adult neural stem and progenitor cells [77]. Conductive pol-
ycaprolactone/CHI/polypyrrole composites were prepared
and characterized in view of their possible use for peripheral
nerve repair [78]; conductive conduits made with polypyr-
role particles dispersed in a CHI-g-polycaprolactone matrix
were prepared and characterized by the same group, then
implanted into rabbits for various periods, to test the vari-
ations of their properties during bioresorption in vivo [79];
however, no data about a test of them as nerve repair conduits
have been reported. To design a novel kind of scaﬀolds for
blood vessel and nerve repairs, random and aligned nano-
fibrous scaﬀolds based on collagen-CHI-thermoplastic poly-
urethane blends were electrospun to mimic the compo-
nential and structural aspects of the native extracellular
matrix. Vascular grafts and nerve conduits were electrospun
or sutured based on the nanofibrous scaﬀolds; the results
indicated that nanofibrous scaﬀolds, made blending colla-
gen, CHI, and thermoplastic polyurethane might be a po-
tential candidate for vascular repair and nerve regenera-
tion [80]. Another group developed an aligned CHI-poly-
caprolactone fibrous scaﬀold and investigated how the fibre
alignment influenced nerve cell organization and function
in comparison with randomly oriented fibrous scaﬀolds
and cast films of the same material. Schwann cells grown
on the aligned CHI-polycaprolactone fibres exhibited a
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Table 1: CHI-containing devices used for bone and nerve tissue regeneration in humans.
Device Tissue Time Reference
CHI ascorbate gel periodontium 2 months [35]
Me-pyrrolidinone-CHI gel tooth alveolar bone 6 months [36]
DCMC-CaPa gel or solution mandible bone 15 days [41]
CHI conduits with PGAb filaments right arm median nerve 36 months [86]
a
N,N-dicarboxymethyl CHI with calcium phosphate;
bpoly(glycolic acid).
bipolar morphology that oriented along the fibre align-
ment direction, while those on the films and randomly
oriented fibres had a multipolar morphology. Similarly,
the CHI-polycaprolactone material supported neuron-like
PC-12 cell adhesion, and the aligned fibres regulated
the growth of PC-12 cells along the fibre orientation.
Additionally, PC-12 cells cultured on the aligned fibres
exhibited enhanced unidirectional neurite extension along
fibre orientation and significantly higher β-tubulin gene
expression than those grown on CHI-polycaprolactone films
and randomly oriented fibres. The results reported suggest
that the aligned CHI-polycaprolactone fibres can serve as
a suitable scaﬀold for improved nerve tissue reconstruc-
tion [81]. The diﬀerentiation of bone marrow stromal
cells in three-dimensional scaﬀolds consisting of collagen,
poly(lactide-co-glycolide), and CHI was also investigated.
The induction with neuron growth factor inhibited osteo-
genesis and guided the diﬀerentiation of bone marrow stro-
mal cells towards neurons in the constructs. Therefore, the
combination of collagen-functionalized poly(lactide-co-gly-
colide)/CHI scaﬀolds, neuron growth factor, and bone
marrow stromal cells can be promising in neural tissue en-
gineering [82]. Indeed, bone marrow stromal cells are gen-
erally known to be useful for bone tissue regeneration [83].
To have found a possible use of them also for nerve tissue
regeneration opens new ways to neural surgery.
Regarding the aim of using bioresorbable macromolec-
ular materials to make nerve regeneration conduits to be
employed in the clinical practice of human neural surgery,
it has been reached since quite several years, both with only
synthetic bioresorbable polyesters [84, 85] and with blends of
them with CHI [86]. In the latter case, a 37-year-old Chinese
man, having a 35mm-long nerve defect in the median nerve
of the right arm at elbow level, underwent a surgical repair
with an artificial nerve graft, comprising an outer micro-
porous conduit of CHI and internal oriented filaments of
poly(glycolic acid). Suitable functional recovery of the hand
ability proceeded slowly, but regularly, with time, together
with nerve regeneration, and was near complete 36 months
after the implantation [86]. The same Chinese surgeon group
reviewed the construction of tissue-engineered nerve grafts
and their application in peripheral nerve regeneration very
recently [87]. As regarding the use of CHI-containing grafts
in clinical neural surgery, only their preceding intervention
was reported, in comparison with many equally successful
ones with other biomaterials. This fact might be a sign that
CHI-containing nerve grafts still need much theoretical and
laboratory study before becoming of common practice in
surgery.
5. Conclusion
The importance of the biomaterials containing either CHI
or CHI derivatives for the regeneration of damaged bone,
cartilage, and nerve tissue appears evident from the studies
carried out near towards the entire world. However, as it
can be seen from the data summarized in Table 1, only few
applications to the human health in this field have been done
at the present time. Then, much work must still be made,
especially for the passage from the experimentation of the
CHI-based devices in vitro and in animals, in which many
successful results were obtained, to their general application
in clinical practice.
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